BNP Paribas Exane Issues Pessimistic Forecast for Procter & Gamble (NYSE:PG) Stock Price

Procter & Gamble (NYSE:PGGet Free Report) had its price target dropped by analysts at BNP Paribas Exane from $172.00 to $164.00 in a research report issued to clients and investors on Friday,MarketScreener reports. The firm presently has an “outperform” rating on the stock. BNP Paribas Exane’s price target would suggest a potential upside of 13.46% from the stock’s previous close.

Several other research analysts have also issued reports on PG. Barclays set a $155.00 price target on Procter & Gamble in a research report on Friday. Cowen reissued a “buy” rating on shares of Procter & Gamble in a research note on Thursday, January 8th. Bank of America lowered their target price on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Raymond James Financial reduced their price target on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research report on Monday, October 20th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Procter & Gamble in a research report on Monday, December 29th. Fifteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $168.36.

Check Out Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Trading Down 0.1%

Shares of PG stock traded down $0.08 on Friday, reaching $144.55. 11,518,068 shares of the stock were exchanged, compared to its average volume of 9,217,492. The stock has a 50 day moving average price of $144.72 and a 200 day moving average price of $150.98. The stock has a market cap of $337.77 billion, a PE ratio of 21.10, a P/E/G ratio of 4.88 and a beta of 0.39. Procter & Gamble has a one year low of $137.62 and a one year high of $179.99. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.71 and a quick ratio of 0.51.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The company had revenue of $22.39 billion for the quarter, compared to the consensus estimate of $22.23 billion. During the same period in the prior year, the company posted $1.93 EPS. The company’s revenue was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Equities research analysts forecast that Procter & Gamble will post 6.91 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CAO Matthew W. Janzaruk sold 725 shares of the business’s stock in a transaction on Thursday, October 30th. The shares were sold at an average price of $149.57, for a total transaction of $108,438.25. Following the transaction, the chief accounting officer owned 979 shares in the company, valued at $146,429.03. The trade was a 42.55% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.20% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the company. Howard Capital Management Group LLC boosted its stake in shares of Procter & Gamble by 1.4% in the 4th quarter. Howard Capital Management Group LLC now owns 8,357 shares of the company’s stock worth $1,198,000 after buying an additional 117 shares during the last quarter. Sharp Wealth Advisory LLC bought a new stake in Procter & Gamble during the fourth quarter worth $349,000. Balboa Wealth Partners boosted its position in Procter & Gamble by 14.7% in the fourth quarter. Balboa Wealth Partners now owns 7,025 shares of the company’s stock worth $1,007,000 after purchasing an additional 901 shares during the last quarter. Heck Capital Advisors LLC grew its stake in Procter & Gamble by 6.7% in the 4th quarter. Heck Capital Advisors LLC now owns 24,972 shares of the company’s stock valued at $3,579,000 after purchasing an additional 1,561 shares during the period. Finally, Hopwood Financial Services Inc. increased its position in shares of Procter & Gamble by 2.5% during the 4th quarter. Hopwood Financial Services Inc. now owns 5,880 shares of the company’s stock valued at $843,000 after purchasing an additional 144 shares during the last quarter. 65.77% of the stock is owned by institutional investors.

Procter & Gamble News Summary

Here are the key news stories impacting Procter & Gamble this week:

About Procter & Gamble

(Get Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Recommended Stories

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.